US 8,575,348 B2Granted

Quinolone inhibitors of lipoprotein-associated phospholipase A2

AssigneeAuspex Pharmaceuticals, Inc.

InventorsTadimeti Rao, Chengzhi Zhang

Life of this patent

Estimating the term…

Abstract

The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.

Claims26

Dependent claims

A compound selected from the group consisting of

Dependencies are inferred from the claim text.

Facts

Application: 12/845,384Filed 28 Jul 2010 · us provisional application
Priority: 28 Jul 2009
Published: US 2011/0136861 A19 Jun 2011
Granted: 5 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07D 401/12
Containing two hetero rings: linked by a chain containing hetero atoms as chain links
A61K 31/4709
Quinolines; Isoquinolines: non-condensed quinolines and containing further heterocyclic rings
A61P 9/00
Drugs for disorders of the cardiovascular system
A61P 11/06
Drugs for disorders of the respiratory system: antiasthmatics

Family

Application61/229,025Us provisional application · filed 28 Jul 2009
US 2011/0136861 A1Pre-grant publication · published 9 Jun 2011
US 8,575,348 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results